---
layout: entry
title: "SARS-CoV-2 Pandemic and The Need for Transplant-oriented Trials"
link: "https://doi.org/10.1111/tri.13626"
author:
- Zaza, Gianluigi; Benedetti, Claudia; Fribourg, Miguel; Maggiore, Umberto; Azzi, Jamil; Riella, Leonardo V.; Cravedi, Paolo

summary:
- "the first reported case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Wuhan, China, in December 2019, the contagion has spread rapidly. There are no published studies beyond the case series describing the incidence and clinical course of COVID-19 in transplant recipients. This pandemic has had a major impact in transplant physicians and healthcare workers as well. The crisis has meant reducing or even interrupting transplant program activity, with a subsequent impact on patient morbidity and mortality still hard to quantify case series in China in December 2019 has been reported in China, the congout has spread quickly."

original:
- "After the first reported case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Wuhan, China, in December 2019, the contagion has spread rapidly and has become a global pandemic.(1) There are as of yet no published studies beyond the case series describing the incidence and clinical course of COVID-19 in transplant recipients, a population potentially at high risk due to the ongoing immunosuppression and higher risk of comorbidities.(2) This pandemic has had a major impact in transplant physicians and healthcare workers as well(3) and this crisis has meant reducing or even interrupting transplant program activity, with a subsequent impact on patient morbidity and mortality that is still hard to quantify."
---

